Document Classification

Section Type: RESULTS

Text: However, there were some tendencies to positive differences between Asp Mg versus placebo on the following : 1) prolonged delay of BZD use if reintake (30 days vs 20 days, p [log-rank] = 0. 5) ; 2) reduction of withdrawal intensity : 11 % of important difficulties during BZD cessation versus 23 % with placebo (p = 0. 2) and on Benzodiazepine Withdrawal Symptoms Questionnaire (BWSQ) (final score 4. 0 vs 4. 8, p = 0. 10) ; 3) lower modification of anxiety during BZD tapering and discontinuation (rate of increase on HAM-A between d30-d90 of 6 % vs 23 % in placebo group, p = 0. 10).